Concentration (nM) | D1D2 | 2DLT | T20 | T1144 | ||||
---|---|---|---|---|---|---|---|---|
IC50 | IC90 | IC50 | IC90 | IC50 | IC90 | IC50 | IC90 | |
HIV-1 IIIB-mediated cell fusion | ||||||||
 | 97.83 | 137.18 | 19.03 | 46.51 | 20.15 | 41.71 | 5.89 | 15.26 |
HIV-1 replication | ||||||||
IIIB (B, X4) | 56.80 | 246.02 | 5.64 | 28.79 | 17.26 | 117.21 | 2.13 | 35.23 |
Bal (B, R5) | 170.20 | >250 | 10.78 | 44.35 | 43.35 | >250 | 4.03 | 28.11 |
92US657 (B, R5)* | >250 | >250 | 17.17 | 51.85 | 56.07 | 223.92 | 13.21 | 42.26 |
93 MW959 (C, R5)* | >250 | >250 | 18.93 | 48.86 | 4.70 | 18.76 | 2.35 | 16.25 |
92TH009 (E/A, R5)* | 25.30 | 113.69 | 17.50 | 71.93 | 1.43 | 7.99 | 1.36 | 6.21 |